Torrent Pharmaceuticals Limited
TORNTPHARM
Clasificación en acciones
#1203
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Precio por acción
$50.16
Capitalización bursátil
$19.08B
Cambio (1 día)
-0.30%
Cambio (1 año)
22.94%
País
IN
Comercio Torrent Pharmaceuticals Limited (TORNTPHARM)
Categoría
Healthcare
Ingresos de Torrent Pharmaceuticals Limited (TORNTPHARM)
Ingresos en Jun 2026 TTM: $1.72B
Según los últimos informes financieros de Torrent Pharmaceuticals Limited, los ingresos actuales de la empresa (TTM) son $1.72B. En 2024, la empresa obtuvo unos ingresos de $1.29B un aumento con respecto a los ingresos del año 2023, que fueron de $1.17B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Torrent Pharmaceuticals Limited desde 2005 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.72B | 27.98% |
| 2025 | $1.35B | 4.66% |
| 2024 | $1.29B | 9.91% |
| 2023 | $1.17B | 4.44% |
| 2022 | $1.12B | 2.50% |
| 2021 | $1.09B | 3.76% |
| 2020 | $1.05B | -4.62% |
| 2019 | $1.10B | 20.92% |
| 2018 | $913.81M | 1.90% |
| 2017 | $896.80M | -10.88% |
| 2016 | $1.01B | 34.94% |
| 2015 | $745.76M | -3.94% |
| 2014 | $776.35M | 31.37% |
| 2013 | $590.99M | 15.51% |
| 2012 | $511.64M | 7.45% |
| 2011 | $476.15M | 11.61% |
| 2010 | $426.62M | 32.82% |
| 2009 | $321.20M | -5.13% |
| 2008 | $338.57M | 13.00% |
| 2007 | $299.62M | 37.98% |
| 2006 | $217.15M | 73.11% |
| 2005 | $125.44M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 283.67% |
IN
|
